Omega-3 fatty acid supplementation during pregnancy and respiratory symptoms in children

Chest

Volumn 146, Issue 2, 2014, Pages 373-382

  Escamilla Nuñez, María Consuelo ^a   Barraza Villarreal, Albino ^a   Hernańdez Cadena, Leticia ^a   Navarro Olivos, Efraiń ^a   Sly, Peter D ^b   Romieu, Isabelle ^a,c  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b CURTIN UNIVERSITY   (Australia)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; PLACEBO;

ADULT; ARTICLE; ATOPY; BLOOD SAMPLING; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DYSPNEA; FEMALE; FEVER; HUMAN; INFANT; MALE; MEXICO; NOSE OBSTRUCTION; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; RISK REDUCTION; WHEEZING;

ADOLESCENT; ADULT; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; FRANCE; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREMATURE BIRTH; PRENATAL CARE; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84905638571     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-1432     Document Type: Article

References (25)

1. Rabinovich GA. Inmunopatología Molecular Nuevas Fronteras de la Medicina. Un Nexo Entre la Investigación Biomédica y la Práctica Clínica. Buenos Aires, Argentina: Editorial Panamericana; 2004.
2. Secretaria de Salud. Anuario Estadístico 2009. Presupuesto, daños a la salud, morbilidad y mortalidad. Cuernavaca, Morelos: Secretaria de Salud, Servicios de Salud de Morelos, 2009. http://www.ssm.gob.mx/portal/ page/sist-info-salud/anuarios/2009/A4-2009-PRESUPUESTO-DANOS-A-LA%20SALUD- MORBILIDAD-Y-MORTALIDAD.pdf. Accessed November 18, 2002.
3. Fieselmann JF, Hal BR, Gottrand F. Enfermedades respiratorias. In: Parslow TG, Stites DP, Terr AL, Imboden JB. eds. Inmunogía Básica y Clínica. México, D. F.: El Manual Moderno; 2003:663-678.
4. Gottrand F. Long-chain polyunsaturated fatty acids influence the immune system of infants. J Nutr. 2008;138(9):1807S-1812S.
5. Blümer N, Renz H. Consumption of omega3-fatty acids during perinatal life: role in immuno-modulation and allergy prevention. J Perinat Med. 2007;35(suppl 1):S12-S18. (Pubitemid 46279664)
6. Calder PC. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2007;77(5-6):327-335. (Pubitemid 350198856)
7. Knapp HR. Omega-3 fatty acids in respiratory diseases: a review. J Am Coll Nutr. 1995;14(1):18-23.
8. Prescott SL, Dunstan JA. Prenatal fatty acid status and immune development: the pathways and the evidence. Lipids. 2007;42(9):801-810. (Pubitemid 47585733)
9. Heinzmann A, Mao XQ, Akaiwa M, et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet. 2000;9(4):549-559. (Pubitemid 30154013)
10. Ramakrishnan U, Stein AD, Parra-Cabrera S, et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico. Food Nutr Bull. 2010;31(suppl 2):S108-S116.
11. Ellwood P, Asher MI, Beasley R, et al. The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three Manual. Auckland, New Zealand: ISAAC International Data Centre; 2000.
12. Hernández E, Barraza-Villarreal A, Escamilla-Núñez MC, et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. Allergy Asthma Proc. 2013;34(5):e27-e34.
13. Hernández-Avila M, Romieu I, Parra S, Hernández-Avila J, Madrigal H, Willett W. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex. 1998;40(2):133-140. (Pubitemid 28257123)
14. Cameron A, Trivedi P. R egression Analysis of Count Data. New York, NY: Cambridge Press; 1988.
15. Tantimongkolsuk C, Pornrattanarungsee S, Chiewvit P, Visitsunthorn N, Ungkanont K, Vichyanond P. Pediatric sinusitis: symptom profiles with associated atopic conditions. J Med Assoc Thai. 2005;88(suppl 8):S149-S155. (Pubitemid 43175634)
16. Visser HK. Dietary influences on infection and allergy in infants: introduction. J Nutr. 2008;138(9):1768S-1769S.
17. Wahn HU. Strategies for atopy prevention. J Nutr. 2008;138(9):1770S- 1772S.
18. Lauritzen L, Kjaer TM, Fruekilde MB, Michaelsen KF, Frøkiaer H. Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2-year-old children. Lipids. 2005;40(7):669-676. (Pubitemid 41266305)
19. Birch EE, Khoury JC, Berseth CL, et al. The impact of early nutrition on incidence of allergic manifestations and common respiratory illnesses in children. J Pediatr. 2010;156(6):902-906.
20. Lee TH, Hoover RL, Williams JD, et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med. 1985;312(19):1217-1224. (Pubitemid 15009155)
21. Lee HS, Barraza-Villarreal A, Hernandez-Vargas H, et al. Modulation of DNA methylation states and infant immune system by dietary supplementation with ω-3 PUFA during pregnancy in an intervention study. Am J Clin Nutr. 2013;98(2):480-487.
22. Imhoff-Kunsch B, Stein AD, Martorell R, Parra-Cabrera S, Romieu I, Ramakrishnan U. Prenatal docosahexaenoic acid supplementation and infant morbidity: randomized controlled trial. Pediatrics. 2011;128(3):e505-e512.
23. Kremmyda LS, Vlachava M, Noakes PS, Diaper ND, Miles EA, Calder PC. Atopy risk in infants and children in relation to early exposure to fish, oily fish, or long-chain omega-3 fatty acids: a systematic review. Clin Rev Allergy Immunol. 2011;41(1):36-66.
24. Leermakers ET, Sonnenschein-van der Voort AM, Heppe DH, et al. Maternal fish consumption during pregnancy and risks of wheezing and eczema in childhood: the Generation R Study. Eur J Clin Nutr. 2013;67(4):353-359.
25. Instituto Mexicano del Seguro Social. Informe al Ejecutivo Federal y al Congreso de la Unión sobre la situación financiera y los riesgos del instituto mexicano del seguro social 2010-2011. Mexico, DF: Instituto Mexicano del Seguro Social; 2011:20.